RNA Therapeutics 2018
This could be the end for tozadenant in Parkinson’s disease.
Fund is challenging prevailing ‘amyloid hypothesis’
New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.
Agenda released for 20th Annual Superbugs Event